U.S. flag An official website of the United States government
  1. Home
  2. Food
  3. Food Ingredients & Packaging
  4. Generally Recognized as Safe (GRAS)
  5. GRAS Notice Inventory
  6. Recently Published GRAS Notices and FDA Letters
  1. GRAS Notice Inventory

Recently Published GRAS Notices and FDA Letters

For a full listing of notices and response letters, please visit the inventory database.

GRN No. Substance GRAS Notice FDA Letter
859 2'-fucosyllactose   FDA ceased to evaluate
(in PDF 109 KB)
839 Purified steviol glycosides   FDA has no questions
(in PDF 77 KB)
838 Purified steviol glycosides   FDA has no questions
(in PDF 83 KB)
837 Hydroxytyrosol   FDA ceased to evaluate
(in PDF 54 KB)
835 Ilex guayusa leaf extract   FDA ceased to evaluate
(in PDF 35.24 KB)
830 Chicory flour   FDA ceased to evaluate
(in PDF 53.77 KB)
823 Rebaudioside E   FDA has no questions
(in PDF 757 KB)
822 Curcumin   FDA has no questions
(in PDF 861 KB)
821 Glucosylated steviol glycosides   FDA has no questions
(in PDF 743 KB)
820 Lactobacillus fermentum CECT5716   GRN 820
(in PDF 35.2 KB)
816 Xylooligosaccharides from sugarcane   GRN 816
(in PDF 68.2 KB)
814 Bifidobacterium bifidum BGN4   FDA has no questions
(in PDF 78 KB)
812 Rebaudioside M   FDA has no questions
(in PDF 659 KB)
811 Phospholipase A1 produced by Aspergillus oryzae   FDA has no questions
(in PDF 64 KB)
810 Lactobacillus paracasei subsp. paracasei strain F-19e   GRN 810
(in PDF 178 KB)
       
809 Fractionated whey protein concentrate containing 41% alphalactalbumin   FDA has no questions
(in PDF 315.2 KB)
808 Lipase from Aspergillus tubingensis produced in Trichoderma reesei   FDA has no questions
(in PDF 79.73 KB)
807 Streptococcus salivarius M18   Correction letter issued June 6, 2019
(in PDF 66 KB)
806 Dolomite   GRN 806
(in PDF 275 KB)
805 Apple peel powder   FDA has no questions
(in PDF 522 kB)
802 Endolysin   GRN 802
(in PDF 294 KB)
801 Chymosin enzyme from Camelus dromendarius produce in Aspergillus niger   FDA has no questions
(in PDF 71 KB)
800 Gamma-oryzanol   FDA has no questions
(in PDF 628 kB)
799 Rebaudioside M   FDA has no questions
(in PDF 112 kB)
797 Fructooligosaccharides   FDA has no questions
(in PDF 450 kB)
796 Orange extract (85% hesperidin)   FDA has no questions
(in PDF 459 kB)
795 Purified steviol glycosides   FDA has no questions
(in PDF 106 kB)
794 Shiitake, pea, and rice protein fermented with Lentinula edodes GRN 794
(in PDF 11.9 MB)
FDA ceased to evaluate this notice
(in PDF 57 kB)
793 Cultured corn starch fermented by Corynebacterium stationis   GRN 793
(in PDF 171 KB)
792 Cultured corn starch fermented by Corynebacterium glutamicum   GRN 792
(in PDF 160 KB)
791 Urolithin A   FDA has no questions
(in PDF 61 kB)
790 Steviol glycosides   FDA has no questions
(in PDF 448 kB)
789 Erythritol   FDA has no questions
(in PDF 80 kB)
788 Pea protein   FDA has no questions
(in PDF 246 kB)
787 Quinoa sprout powder   FDA has no questions
(in PDF 94 kB)
786 Calcium propionate   FDA has no questions
(in PDF 70 kB)
785 Calcium chloride   FDA has no questions
(in PDF 74 kB)
784 Siraitia grosvenorii Swingle   FDA has no questions
(in PDF 664 kB)
783 Triacylglycerol lipase from Rhizopus oryzae produced in Aspergillus niger GRN 783
(in PDF 75.5 KB)
FDA has no questions
(in PDF 81 kB)
782 L-arabinose   FDA has no questions
(in PDF 47 kB)
781 Alpha-tocopherol (fruit and vegetable derived) GRN 781
(in PDF 3 MB)
FDA has no questions
(in PDF 1 MB)
780 Rebaudioside M GRN 780
(in PDF 1 MB)
FDA has no questions
(in PDF 115 kB)
779 Isomalto-oligosaccharide mixture GRN 779
(in PDF 12 MB)
FDA has no questions
(in PDF 89 kB)
778 Hemp seed oil GRN 778
(in PDF 19 MB)
GRN 778 Amendment
(in PDF 352 kB)
FDA has no questions
(in PDF 429 kB) 
777 Algal oil (55% docosahexaenoic acid) from Schizochytrium sp. FCC-3204 GRN 777
(in PDF 13.4 MB)
FDA has no questions
(in PDF 230 kB)
776 Algal oil (35% docosahexaenoic acid) from Schizochytrium sp. FCC-1324 GRN 776
(in PDF 1.58 MB)
FDA has no questions
(in PDF 570 kB)
775 colicin proteins produced in Nicotiana benthamiana (colicin preparations) GRN 775
(in PDF 3.34 MB
FDA has no questions
(in PDF 77 kB)
774 Glutaminase from Bacillus licheniformis produced in Bacillus licheniformis GRN 774
(in PDF 1.28 MB
FDA has no questions
(in PDF 73 kB)
773 Dried biomass of Chlamydomonas reinhardtii GRN 773
(in PDF 4.99 MB
Correspondence Correction
(in PDF 149 kB)
772 Palmitoylated green tea catechins GRN 772
(in PDF 1.68 MB
FDA has no questions
(in PDF 63 kB)
771 Hemp seed protein GRN 771 Part 1
(in PDF 4.4 MB)
GRN 771 part 2
(in PDF 14.9MB)
GRN 771 Amendment
(in PDF 352 kB)
FDA has no questions
(in PDF 480 kB)
770 Potassium polyaspartate GRN 770
(in PDF 1.28 MB
FDA has no questions
(in PDF 786 kB)
769 Vitamin C (fruit and vegetable derived) GRN 769
(in PDF 770 KB
FDA has no questions
(in PDF 72 kB)
768 Stevia leaf extract GRN 768
(in PDF 2 MB)
FDA has no questions
(in PDF 100 kB)
767 Polyvinyl alcohol GRN 767
(in PDF 502.88 KB
FDA has no questions
(in PDF 57 kB)
766 3’-sialyllactose sodium salt GRN 766
(in PDF 919 KB)
Correspondence Correction
(in PDF 850 kB)
FDA has no questions
(in PDF 82 kB)
765 Hulled hemp seed GRN 765
(in PDF 19 MB)
GRN 765 Amendment
(in PDF 352 kB)
FDA has no questions
(in PDF 273 kB)
764 Rebaudioside D GRN 764
(in PDF 8.46 MB
FDA has no questions
(in PDF 111 kB)
763 Alpha-lactalbumin GRN 763
(in PDF 1.9 MB
FDA has no questions
(in PDF 106 kB)
762 Carnobacterium divergens M35 preparation GRN 762
(in PDF 5.4 MB
FDA has no questions
(in PDF 32 kB)
761 Esterified propoxylated glycerol GRN 761
(in PDF 3.2 MB
FDA has no questions
(in PDF 106 kB)
760 Lactobacillus curvatus DSM 18775 GRN 760
(in PDF 3.7 MB)
FDA has no questions
(in PDF 77 kB)
759 Steviol glycosides consisting primarily of rebaudioside M produced in Yarrowia lipolytica GRN 759
(in PDF 3.7 MB)
FDA has no questions
(in PDF 106 kB)
758 Lactobacillus helveticus R0052, Bifidobacterium longum ssp. infantis R0033, and Bifidobacterium bifidum R0071 GRN 758
(in PDF 5 MB)
FDA has no questions
(in PDF 103 kB)
757 Escherichia coli O157 GRN 757
(in PDF 2 MB)
FDA has no questions
(in PDF 67 kB)
756 Endo-1,4-beta-glucanase from Trichoderma reesei GRN 756
(in PDF 3.5 MB)
 
755 D-psicose GRN 755
(in PDF 545 kB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 57 kB)
754 Algal oil (87% oleic acid) derived from Prototheca moriformis strain S6697 GRN 754
(in PDF 15 MB)
FDA has no questions
(in PDF 87 kB)
753 Sodium Thiocyanate GRN 753
(in PDF 6.9 MB)
FDA has no questions
(in PDF 56 kB)
752 Preparation containing the bacterial monophages, BP-63 and LVR16-A, specific to Salmonella GRN 752
(in PDF 2.3 MB)
FDA has no questions
(in PDF 57 kB)
751 Maltogenic alpha-amylase from Bacillus stearothermophilus produced in Bacillus subtilis GRN 751
(in PDF 1.1 MB)
FDA has no questions
(in PDF 228 kB)
750 Beta-glucosidase GRN 750 Part 1
(in PDF 7.7 MB)
GRN 750 Part 2
(in PDF 16.4 MB)
GRN 750 Part 3
(in PDF 14 MB)
GRN 750 Part 4
(in PDF 20 MB)
FDA has no questions
(in PDF 767 kB)
749 2’-O-fucosyllactose GRN 749 Part 1
(in PDF 10.6 MB)
GRN 749 Part 2
(in PDF 12.2 MB)
FDA has no questions
(in PDF 96 kB)
748 Tomato powder GRN 748
(in PDF 3.4 MB)
FDA ceased to evaluate
(in PDF 45 kB)
747 Calcium lactate GRN 747
(in PDF 2.2 MB)
FDA has no questions
(in PDF 76 kB)
746 Maltogenic amylase from Geobacillus stearothermophilus produced in Bacillus subtilis GRN 746
(in PDF 7.1 MB)
FDA has no questions
(in PDF 104 kB)
745 Steviol glycosides consisting primarily of rebaudioside M GRN 745
(in PDF 1 MB)
FDA has no questions
(in PDF 139 kB)
744 Steviol glycosides consisting primarily of rebaudioside M GRN 744
(in PDF 1.9 MB)
FDA has no questions
(in PDF 131 kB)
743 β-galactosidase from Papiliotrema terrestris GRN 743
(in PDF 8.7 MB)
FDA has no questions
(in PDF 69 kB)
742 Duckweed (subfamily Lemnoideae) powder GRN 742 Part 1
(in PDF 9 MB)
GRN 742 Part 2
(in PDF 8.7 MB)
GRN 742 Part 3
(in PDF 11.5 MB)
FDA has no questions
(in PDF 64 kB)
741 Dimethyl ether GRN 741
(in PDF 403 kB)
FDA has no questions
(in PDF 72 kB)
740 Glycolipids from Dacryopinax spathularia GRN 740
(in PDF 3.7 MB)
FDA has no questions
(in PDF 94 kB)
739 Mannanase enzyme from Talaromyces leycettanus produced in Aspergillus niger GRN 739
(in PDF 622 kB)
FDA has no questions
(in PDF 113 kB)
738 Thaumatin GRN 738
(in PDF 1.8 MB)
FDA has no questions
(in PDF 77 kB)
737 Soy leghemoglobin GRN 737 Part 1
(in PDF 10.1 MB)
GRN 737 Part 2
(in PDF 9.2 MB)
GRN 737 Part 3
(in PDF 10.4 MB)
FDA has no questions
(in PDF 80 kB)
736 Lactobacillus casei subsp. paracasei Lpc-37 GRN 736
(in PDF 17.6 MB)
FDA has no questions
(in PDF 73 kB)
735 2’-Fucosyllactose GRN 735 Part 1
(in PDF 15.5 MB)
GRN 735 Part 2
(in PDF 16.3 MB)
GRN 735 Part 3
(in PDF 10.3 MB),
GRN 735 Part 4
(in PDF 14.8 MB)
FDA has no questions
(in PDF 103 kB)
734 Ergothionine GRN 734
(in PDF 18.5 MB)
FDA has no questions
(in PDF 70 kB)
733 Purified steviol glycosides GRN 733 Part 1
(in PDF 9.8 MB)
GRN 733 Part 2
(in PDF 15 MB)
FDA has no questions
(in PDF 69 kB)
732 Docosahexaenoic acid oil produced in Schizochytrium sp. GRN 732
(in PDF 5.3 MB)
FDA has no questions
(in PDF 68 kB)
731 Docosahexaenoic acid oil produced in Schizochytrium sp. GRN 731
(in PDF 454 kB)
FDA has no questions
(in PDF 72 kB)
730 Arachidonic Acid Oil Produced in Mortierella Alpina GRN 730
(in PDF 6.8 MB)
FDA has no questions
(in PDF 77 kB)
729 Galacto-oligosaccharides GRN 729
(in PDF 15 MB)
FDA has no questions
(in PDF 112 kB)
728 Phospholipase C from Pseudomonas sp. 62186 produced in Bacillus licheniformis GRN 728
(in PDF 730 kB)
FDA has no questions
(in PDF 47 kB)
727 Trehalase from Trichoderma reesei produced in Trichoderma reesei GRN 727
(in PDF 4.9 MB)
FDA has no questions
(in PDF 61 kB)
726 Polyphenol extract from olive GRN 726
(in PDF 7.5 MB)
FDA has no questions
(in PDF 66 kB)
725 Inactivated Bacillus coagulans GBI-30, 6086 GRN 725
(in PDF 5.2 MB)
FDA has no questions
(in PDF 52 kB)
724 Preparation containing six bacterial phages specific to shiga-toxin producing Escherichia coli   GRN 724
(in PDF 4.2 MB)
FDA has no questions
(in PDF 75 kB)
723 Benzalkonium chloride GRN 723
(in PDF 18.6 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 41 kB)
722 Lactobacillus plantarum Lp-115 GRN 722
(in PDF 10.3 MB)
FDA has no questions
(in PDF 67 kB)
721 Galacto-oligosaccharides GRN 721
(in PDF 10 MB)
FDA has no questions
(in PDF 69 kB)
720 Rice bran wax GRN 720
(in PDF 23.4 MB)
FDA has no questions
(in PDF 73 kB)
719 Orange pomace GRN 719
(in PDF 2.1 MB)
FDA has no questions
(in PDF 66 kB)
718 Calcium acid pyrophosphate GRN 718
(in PDF 885 kB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 32 kB)
717 Short-chain fructo-oligosaccharides GRN 717
(in PDF 4.1 MB)
FDA has no questions
(in PDF 82 kB)
716 Bovine milk osteopontin GRN 716 Part 1
(in PDF 17.4 MB)
GRN 716 Part 2
(in PDF 483 kB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 32 kB)
715 Rebaudioside D GRN 715
(in PDF 2.9 MB)
FDA has no questions
(in PDF 69 kB)
714 Subtilisin from Bacillus amyloliquefaciens produced in Bacillus subtilis GRN 714
(in PDF 10.8 MB)
FDA has no questions
(in PDF 53 kB)
713 Hydrolyzed pork cartilage GRN 713
(in PDF 636 kB)
FDA has no questions
(in PDF 65 kB)
712 Calcium acetate GRN 712
(in PDF 11.9 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 44 kB)
711 Glucan GRN 711
(in PDF 1.8 MB)
FDA has no questions
(in PDF 49 kB)
710 Basic methacrylate copolymer GRN 710
(in PDF 414 kB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 50 kB)
709 Pyrroloquinoline quinone disodium salt GRN 709
(in PDF 1.55 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 79 kB)
708 Triacylglycerol lipase from Rhizopus oryzae produced in Aspergillus niger   At the notifier's request, FDA ceased to evaluate this notice
(in PDF 52 kB)
707 Glucose oxidase from Penicillium produced in Trichoderma reesei GRN 707
(in PDF 22 MB)
FDA has no questions
(in PDF 51 kB)
706 Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract GRN 706
(in PDF 16.6 MB)
FDA has no questions
(in PDF 93 kB)
705 Distarch phosphate GRN 705
(in PDF 21.1 MB)
FDA has no questions
(in PDF 63 kB)
704 Corn oil (by-product of ethanol production) GRN 704
(in PDF 8.8 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 67 kB)
703 Alpha-glucosidase from Aspergillus niger produced by Trichoderma reesi GRN 703
(in PDF 10 MB)
FDA has no questions
(in PDF 128 kB)
702 Purified steviol glycosides GRN 702
(in PDF 11.5 MB)
FDA has no questions
(in PDF 65 kB)
701 Pyrroloquinoline quinone disodium salt GRN 701
(in PDF 3.7 MB)
FDA has no questions
(in PDF 68 kB)
700 Paracoccus carotinifaciens extract containing carotenoids GRN 700
(in PDF 17 MB)
FDA has no questions
(in PDF 99 kB)
699 Trehalase from Myceliophthora sepedonium produced by Aspergillus niger GRN 699
(in PDF 4.2 MB)
FDA has no questions
(in PDF 67 kB)
698 Paramylon isolate from Euglena gracilis GRN 698
(in PDF 4.7 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 105 kB)
697 Dried biomass of Euglena gracilis GRN 697
(in PDF 4.8 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 105 kB)
696 Dolomite GRN 696
(in PDF 897 kB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 53 kB)
695 Dimethyl ether GRN 695
(in PDF 1.8 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 46 kB)
694 Pyrroloquinoline quinone disodium salt (PQQ) GRN 694
(in PDF 6.7 MB)
FDA has no questions
(in PDF 72 kB)
693 D-psicose GRN 693
(in PDF 1.6 MB)
FDA has no questions
(in PDF 97 kB)
692 Quinoa sprout extract GRN 692
(in PDF 1.8 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 33 kB)
691 Bacillus coagulans SANK 70258 spore preparation GRN 691
(in PDF 14.3 MB)
FDA has no questions
(in PDF 54 kB)
690 Fruit and vegetable vitamin extract GRN 690
(in PDF 4.1 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 117 kB)
689 Phospholipase C from Bacillus thuringiensis produced in Bacillus licheniformis GRN 689
(in PDF 870 kB)
FDA has no questions
(in PDF 54 kB)
688 Sodium thiocyanate GRN 688
(in PDF 2.2 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 47 kB)
687 Inulin from Agave tequilana GRN 687
(in PDF 16.5 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 54 kB)
686 Curcumin from turmeric (Curcuma longa L.) GRN 686
(in PDF 5.2 MB)
FDA has no questions
(in PDF 152 kB)
685 Lactobacillus plantarum strain 299v GRN 685
(in PDF 4.8 MB)
FDA has no questions
(in PDF 44 kB)
684 Mung bean protein isolate GRN 684
(in PDF 8.3 MB)
FDA has no questions
(in PDF 119 kB)
683 Canola protein isolate GRN 683
(in PDF 13.6 MB)
FDA has no questions
(in PDF 75 kB)
682 Lecithin from canola GRN 682
(in PDF 7.2 MB)
FDA has no questions
(in PDF 151 kB)
681 Dried isomaltulose syrup GRN 681
(in PDF 7.3 MB)
FDA has no questions
(in PDF 151 kB)
680 Alpha-L-arabinofuranosidase from Talaromyces pinophilus produced by Trichoderma reesei GRN 680
(in PDF 639 kB)
FDA has no questions
(in PDF 101 kB)
679 Dealcoholized fermented orange juice GRN 679
(in PDF 2.2 MB)
FDA has no questions
(in PDF 67 kB)
678 Alpha-cyclodextrin GRN 678
(in PDF 5.5 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 49 kB)
677 Docosahexaenoic acid oil produced in Schizochytrium sp. GRN 677
(in PDF 12.3 MB)
FDA has no questions
(in PDF 101 kB)
676 Colicin GRN 676
(in PDF 1.9 MB)
FDA has no questions
(in PDF 90 kB)
675 Xylanase enzyme preparation produced by Trichoderma reesei carrying a xylanase gene from Talaromyces leycettanus GRN 675
(in PDF 776 kB)
FDA has no questions
(in PDF 76 kB)
674 Isomalto-oligosaccharides GRN 674
(in PDF 1.2 MB)
FDA has no questions
(in PDF 160 kB)
673 Algal fat derived from Prototheca moriformis (S7737) GRN 673
(in PDF 15.3 MB)
FDA has no questions
(in PDF 76 kB)
672 Preparation containing five bacterial monophages specific to Shigella spp. GRN 672
(in PDF 1.4 MB)
FDA has no questions
(in PDF 109 kB)
671 Galacto-oligosaccharides (GOS) GRN 671
(in PDF 4 MB)
At the notifier's request, FDA ceased to evaluate this notice
(in PDF 62 kB)
670 Inactivated Bacillus coagulans GBI-30, 6086 GRN 670
(in PDF 325 kB)
FDA has no questions
(in PDF 47 kB)
669 Cow's milk-derived lactoferrin GRN 669 Part 1
(in PDF 9.4 MB)
GRN 669 Part 2
(in PDF 18.3 MB)
GRN 669 Part 3
(in PDF 9.8 MB)
FDA has no questions
(in PDF 168 kB)
668 Sodium formate GRN 668
(in PDF 2.6 MB)
FDA has no questions
(in PDF 106 kB)
667 Rebaudioside M GRN 667
(in PDF 6.5 MB)
FDA has no questions
(in PDF 115 kB)
666 Chondroitin sodium sulfate GRN 666
(in PDF 4.9 MB)
FDA has no questions
(in PDF 109 kB)
665 Lactoperoxidase system GRN 665
(in PDF 658 kB)
At the notifier's request, FDA ceased to evaluate this notice
664 Alpha-amylase from Cytophaga sp. expressed in Bacillus licheniformis GRN 664
(in PDF 1 MB)
FDA has no questions
(in PDF 79 kB)
663 Distarch phosphate GRN 663
(in PDF 2.6 MB)
At the notifier's request, FDA ceased to evaluate this notice
662 Glucosylated steviol glycosides (minimum purity 95%) GRN 662
(in PDF 5.9 MB)
FDA has no questions
661 Fucus vesiculosus concentrate GRN 661
(in PDF 9.7 MB)
FDA has no questions
(in PDF 85 kB)
660 Bacillus coagulans GBI-30, 6086 GRN 660
(in PDF 3.6 MB)
FDA has no questions
(in PDF 81 kB)
659 Lacto-N-neotetraose   FDA has no questions
658 Grapefruit extract   At the notifier's request, FDA ceased to evaluate this notice
657 Glucoamylase from Penicillum oxalicum produced in Aspergillus niger   FDA has no questions
656 Enzyme-modified steviol glycosides   FDA has no questions
655 Rice bran wax   At the notifier's request, FDA ceased to evaluate this notice
654 Cocoa butter substitute   FDA has no questions
653 Lysophospholipase from Aspergillus nishimurae expressed in Trichoderma reesei.   FDA has no questions
652 Gamma linolenic acid safflower oil   FDA has no questions
651 Phospholipase A1 from Talaromyces leycettanus produced in Aspergillus niger   FDA has no questions
650 2'-O-fucosyllactose   FDA has no questions
649 β-galactosidase enzyme preparation from Bacillus circulans produced in Bacillus subtilis   FDA has no questions
648 Monoglycerides   FDA has no questions
647 D-psicose   At the notifier's request, FDA ceased to evaluate this notice
646 Pecan shell fiber   FDA has no questions
645 Pullulanase from Bacillus deramificans and Bacillus acidopullulyticus expressed in Bacillus licheniformis   FDA has no questions
644 Non-fat dry goat milk and goat whey protein   FDA has no questions
643 Phosphatidylserine derived from fish   At the notifier's request, FDA ceased to evaluate this notice
642 Camelina oil   FDA has no questions
641 Pyrroloquinoline quinone disodium salt   FDA has no questions
640 Esterified propoxylated glycerol   FDA has no questions
639 Zeaxanthin from marigold   FDA has no questions
638 High purity steviol glycosides (minimum purity 97%) consisting primarily of rebaudioside A   FDA has no questions
637 Phosphatidylserine derived soy lecithin   At the notifier's request, FDA ceased to evaluate this notice
636 Phosphatidylserine derived from sunflower   At the notifier's request, FDA ceased to evaluate this notice
635 Nicotinamide riboside chloride   FDA has no questions
634 Calcium chloride   FDA has no questions
633 Whey protein   FDA has no questions
632 Rebaudioside A from Yarrowia lipolytica   FDA has no questions
631 Triacylglycerol lipase from Fusarium oxysporum produced in Trichoderma reesei   FDA has no questions
630 Preparation containing the bacterial monophages, Fo1a and S16, specific to Salmonella   At the notifier's request, FDA ceased to evaluate this notice
629 Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract   At the notifier's request, FDA ceased to evaluate this notice
628 endo-1,4-beta-xylanase from Trichoderma reesei   FDA has no questions
627 Siraitia grosvenorii Swingle (Luo Han Guo) fruit juice concentrate   FDA has no further questions
626 Steviol glycosides produced in Saccharomyces cerevisiae   FDA has no questions
625 Pyrroloquinoline quinone disodium salt   FDA has no questions
624 D-allulose 3-epimerase from Arthrobacter globiformis M30 produced in Escherichia coli   FDA has no questions
623 Fructooligosaccharides   FDA has no questions
622 Emulsified fish oil   At the notifier's request, FDA ceased to evaluate this notice
621 Emulsified algal oil   At the notifier's request, FDA ceased to evaluate this notice
620 Galacto-oligosaccharides   FDA has no questions
619 Purified steviol glycosides   FDA has no questions
618 Purified seawater   FDA has no questions
617 α-amylase from Cytophaga sp. produced in Bacillus licheniformis   At the notifier's request, FDA ceased to evaluate this notice
616 High-amylose cornstarch acetate   FDA has no questions
615 High-amylose cornstarch   FDA has no questions
614 Chromium polynicotinate   FDA has no questions
613 Apple peel powder   At the notifier's request, FDA ceased to evaluate this notice
612 Fractionated whey protein isolate containing cow’s milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2   At the notifier's request, FDA ceased to evaluate this notice
611 Fractionated whey protein isolate containing cow’s milk derived lactoferrin, lactoperoxidase, and transforming growth factor β2   At notifier's request, FDA ceased to evaluate the notice
610 Isomaltodextrin   FDA has no questions
609 Rice protein   Additional letter
(in PDF 81 kB)
FDA has no questions
608 Pea protein concentrate   FDA has no questions
607 Glucosylated steviol glycosides (minimum purity 80%)   FDA has no questions
606 Vinyl acetate-vinyl laurate copolymers   FDA has no questions
605 Fructo-oligosaccharides   FDA has no questions
604 Baker's Yeast (Saccharomyces cerevisiae) expressing asparaginase II   FDA has no questions
603 Preparation containing the bacterial monophages, BP-63 and BP-12, specific to Salmonella   FDA has no questions
602 N-acetyl-D-neuraminic acid   FDA has no questions
601 Bacillus coagulans SBC37-01 spore preparation   FDA has no questions
600 Hydroxytyrosol   FDA has no questions
599 Citrus fiber   FDA has no questions
598 Thermolysin enzyme preparation derived from Geobacillus stearothermophilus   FDA has no questions
597 Bacillus coagulans SNZ1969 spores preparation   FDA has no questions
596 Breadfruit flour   FDA has no questions
591 Streptococcus salivarius K12  

FDA has no questions

GRN 591
(in PDF 1.92 MB)

468 Preparation containing the bacterial monophages, Fo1a and S16, specific to Salmonella   Additional correspondence
452 Enzyme-modified steviol glycosides   Additional Correspondence
(in PDF 282 kB)
229 Methylsulfonylmethane   Additional correspondence
(in PDF 45 kB)